Pulsenmore Ltd. (TLV:PULS)
Israel · Delayed Price · Currency is ILS · Price in ILA 326.40
+21.00 (6.88%)
At close: Dec 21, 2025
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 169.37 million as of December 19, 2025. Its market cap has increased by 22.80% in one year.
Market Cap
169.37M
Enterprise Value
84.44M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
326.40
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 169.37M, a decrease of -78.70%. That is a compound annual growth rate of -28.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 21, 2025 | 169.37M | -32.69% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
| Jun 15, 2021 | 795.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.55B |
| Danel (Adir Yeoshua) | 2.75B |
| Kamada | 1.38B |
| BrainsWay | 1.04B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 999.21M |
| Ilex Medical | 737.86M |
| Novolog (Pharm-Up 1966) | 650.34M |